secwatch.observer — SEC 8-K summary
======================================

Issuer:     PULSE BIOSCIENCES, INC. (PLSE)
CIK:        0001625101
Form:       8-K
Filed at:   2024-08-12T23:59:59+00:00
Accession:  0001437749-24-026104
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pulse Biosciences posts updated investor presentation on website; no new financial data disclosed
--------------------------------------------------------------------------------

- Updated deck highlights progress on CellFX nsPFA 360 Cardiac Catheter, Cardiac Surgery System, and Percutaneous Electrode.
- Investor presentation is dated August 2024 and available on company's website.
- No specific milestones, clinical data, or financial guidance included in filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625101/000143774924026104/0001437749-24-026104-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625101/000143774924026104/plse20240812_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-026104

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer